找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Managing Cancer during Pregnancy; Hatem A. Azim Jr Book 2016 Springer International Publishing Switzerland 2016 Cancer in Pregnancy.Chemot

[復制鏈接]
樓主: Clinton
41#
發(fā)表于 2025-3-28 14:37:26 | 只看該作者
Contributions and Risks of Radiation Therapy in Managing Cancer During Pregnancyy shielding can further decrease the foetal dose. Also, in case of multimodality treatment, adaptation of the order of treatment modalities could be considered. Benefits and disadvantages should then be weighed against each other together with the future parents. This chapter gives an overview of th
42#
發(fā)表于 2025-3-28 19:24:54 | 只看該作者
Pharmacokinetics of Systemic Anticancer Therapies During Pregnancyn drug safety in one hand and in drug efficacy in the other hand. We will focus in this chapter on the pharmacokinetic changes occurring during pregnancy leading to potential changes in drug dosing and subsequently in their transplacental transfer. Recent preclinical and clinical available data rega
43#
發(fā)表于 2025-3-28 23:43:43 | 只看該作者
44#
發(fā)表于 2025-3-29 05:51:10 | 只看該作者
Neonatal and Long-Term Consequences of In Utero Exposure to Systemic Anticancer Therapynduce hearing loss, especially when high dosages are used. Since prematurity has been related to decreased cognitive functioning, postponement of delivery can be achieved by maternal cancer treatment during pregnancy. Overall, the use of several chemotherapeutic agents during pregnancy is considered
45#
發(fā)表于 2025-3-29 08:45:09 | 只看該作者
46#
發(fā)表于 2025-3-29 13:17:12 | 只看該作者
Managing Ovarian Tumors During Pregnancyhould be properly informed about the risks and benefits of any procedure. It is recommended that patients are referred to specialized centers that may guarantee the best outcome..Systemic chemotherapy may be safely administered after the second trimester: its use should be carefully evaluated consid
47#
發(fā)表于 2025-3-29 19:27:23 | 只看該作者
48#
發(fā)表于 2025-3-29 20:51:59 | 只看該作者
49#
發(fā)表于 2025-3-30 03:09:59 | 只看該作者
50#
發(fā)表于 2025-3-30 04:36:34 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 23:49
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
桐城市| 米脂县| 巧家县| 始兴县| 米脂县| 屯留县| 巍山| 蒙自县| 嵊州市| 延吉市| 治县。| 太原市| 民丰县| 陆良县| 武乡县| 通河县| 南丹县| 阿拉善盟| 塔城市| 茂名市| 三江| 岳阳县| 岳普湖县| 东阿县| 贵溪市| 通江县| 酒泉市| 临颍县| 金门县| 县级市| 卓尼县| 丰台区| 会东县| 隆尧县| 溧水县| 泰安市| 郎溪县| 佛冈县| 益阳市| 信宜市| 德化县|